Search Results

There are 28447 results for: content related to: Association of Polymorphisms in the Solute Carrier Organic Anion Transporter Family Member 1B1 Gene with Essential Hypertension in the Uyghur Population

  1. You have free access to this content
    The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 4, October 2014, Pages: 423–428, L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden, Q Feng, R M Cooper-DeHoff, L Gong, T E Klein, M Wadelius and M Niemi

    Version of Record online : 11 JUN 2014, DOI: 10.1038/clpt.2014.125

    Corrected by:

    Translation: The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

    Vol. 92, Issue 1, 112–117, Version of Record online: 23 MAY 2012

  2. Influence of SLCO1B1 Polymorphisms on the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 11, November 2012, Pages: 1725–1738, Dr Christina L. Aquilante, Dr Jennifer J. Kiser, Dr Peter L. Anderson, Dr Uwe Christians, Dr Lisa A. Kosmiski, Ms Elizabeth B. Daily, Mr Keith L. Hoffman, Mr Charles W. Hopley, Ms Julie A. Predhomme, Mr Bjorn Schniedewind and Ms Maha S. Sidhom

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011427907

  3. Organic anion transporter 1B1 (SLCO1B1) polymorphism and gallstone formation: High incidence of Exon4 CA genotype in female patients in North India

    Hepatology Research

    Volume 41, Issue 1, January 2011, Pages: 71–78, Anshika Srivastava, Anvesha Srivastava, Neena Srivastava, Gourdas Choudhuri and Balraj Mittal

    Version of Record online : 25 OCT 2010, DOI: 10.1111/j.1872-034X.2010.00736.x

  4. Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide

    The Journal of Clinical Pharmacology

    Volume 48, Issue 3, March 2008, Pages: 311–321, Annikka Kalliokoski, Mikko Neuvonen, Pertti J. Neuvonen and Mikko Niemi

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007311569

  5. High-Specificity Single-Tube Multiplex Genotyping Using Ribo-PAP PCR, Tag Primers, Alkali Cleavage of RNA/DNA Chimeras and MALDI-TOF MS

    Human Mutation

    Volume 34, Issue 1, January 2013, Pages: 266–273, Florence Mauger, David H. Gelfand, Amar Gupta, Veeraiah Bodepudi, Stephen G. Will, Keith Bauer, Thomas W. Myers and Ivo G. Gut

    Version of Record online : 8 NOV 2012, DOI: 10.1002/humu.22227

  6. OATP1B1 POLYMORPHISM IS A MAJOR DETERMINANT OF SERUM BILIRUBIN LEVEL BUT NOT ASSOCIATED WITH RIFAMPICIN-MEDIATED BILIRUBIN ELEVATION

    Clinical and Experimental Pharmacology and Physiology

    Volume 34, Issue 12, December 2007, Pages: 1240–1244, Wei Zhang, Yi-Jing He, Zhou Gan, Lan Fan, Qing Li, An Wang, Zhao-Qian Liu, Sheng Deng, Yuan-Fei Huang, Lin-Yong Xu and Hong-Hao Zhou

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1440-1681.2007.04798.x

  7. You have free access to this content
    The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 1, July 2012, Pages: 112–117, R A Wilke, L B Ramsey, S G Johnson, W D Maxwell, H L McLeod, D Voora, R M Krauss, D M Roden, Q Feng, R M Cooper-DeHoff, L Gong, T E Klein, M Wadelius and M Niemi

    Version of Record online : 23 MAY 2012, DOI: 10.1038/clpt.2012.57

    This article corrects:
  8. Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia

    Clinical Pharmacology & Therapeutics

    Volume 99, Issue 6, June 2016, Pages: 651–660, CD Drenberg, SW Paugh, SB Pounds, L Shi, SJ Orwick, L Li, S Hu, AA Gibson, RC Ribeiro, JE Rubnitz, WE Evans, A Sparreboom and SD Baker

    Version of Record online : 20 FEB 2016, DOI: 10.1002/cpt.315

  9. Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia

    Pediatric Blood & Cancer

    Volume 57, Issue 4, October 2011, Pages: 612–619, Elixabet Lopez-Lopez, Idoia Martin-Guerrero, Javier Ballesteros, M. Angeles Piñan, Purificacion Garcia-Miguel, Aurora Navajas and Africa Garcia-Orad

    Version of Record online : 8 MAR 2011, DOI: 10.1002/pbc.23074

  10. Factors Associated with Variability in Rifampin Plasma Pharmacokinetics and the Relationship between Rifampin Concentrations and Induction of Efavirenz Clearance

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 3, March 2014, Pages: 265–271, Awewura Kwara, Lei Cao, Hongmei Yang, Pamela Poethke, Jaclynn Kurpewski, Karen T. Tashima, Behrang D. Mahjoub, Michael H. Court and Charles A. Peloquin

    Version of Record online : 13 JAN 2014, DOI: 10.1002/phar.1388

  11. You have free access to this content
    Influence of Genomic Ancestry on the Distribution of SLCO1B1, SLCO1B3 and ABCB1 Gene Polymorphisms among Brazilians

    Basic & Clinical Pharmacology & Toxicology

    Volume 110, Issue 5, May 2012, Pages: 460–468, Vinicius de A. Sortica, Elida B. Ojopi, Júlia P. Genro, Sidia Callegari-Jacques, Ândrea Ribeiro-dos-Santos, Manoel Odorico de Moraes, Marco A. Romano-Silva, Sérgio D. J. Pena, Guilherme Suarez-Kurtz and Mara H. Hutz

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1742-7843.2011.00838.x

  12. You have free access to this content
    Fentanyl Pharmacokinetics is not Dependent on Hepatic Uptake by Organic Anion-Transporting Polypeptide 1B1 in Human Beings

    Basic & Clinical Pharmacology & Toxicology

    Volume 113, Issue 1, July 2013, Pages: 43–48, Victoria C. Ziesenitz, Sonja K. König, Nina Mahlke, Ricarda Jantos, Gisela Skopp, Johanna Weiss, Walter E. Haefeli and Gerd Mikus

    Version of Record online : 6 APR 2013, DOI: 10.1111/bcpt.12066

  13. Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG-CoA Reductase Inhibitors: A Kinetic Consideration of Its Mechanism

    Clinical Pharmacology & Therapeutics

    Volume 94, Issue 1, July 2013, Pages: 37–51, Y Tomita, K Maeda and Y Sugiyama

    Version of Record online : 7 NOV 2012, DOI: 10.1038/clpt.2012.221

  14. Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia

    Pediatrics International

    Volume 57, Issue 4, August 2015, Pages: 572–577, Ryoko Suzuki, Hiroko Fukushima, Emiko Noguchi, Masahiro Tsuchida, Nobutaka Kiyokawa, Kazutoshi Koike, Enbo Ma, Hideto Takahashi, Chie Kobayashi, Ryoko Nakajima-Yamaguchi, Aiko Sakai, Makoto Saito, Atsushi Iwabuchi, Keisuke Kato, Tomohei Nakao, Ai Yoshimi, Ryo Sumazaki and Takashi Fukushima

    Version of Record online : 28 AUG 2015, DOI: 10.1111/ped.12682

  15. You have free access to this content
    SLCO1B1 Polymorphism and Oral Antidiabetic Drugs

    Basic & Clinical Pharmacology & Toxicology

    Volume 107, Issue 4, October 2010, Pages: 775–781, Annikka Kalliokoski, Pertti J. Neuvonen and Mikko Niemi

    Version of Record online : 15 APR 2010, DOI: 10.1111/j.1742-7843.2010.00581.x

  16. A Genome-Wide Association Study for Serum Bilirubin Levels and Gene-Environment Interaction in a Chinese Population

    Genetic Epidemiology

    Volume 37, Issue 3, April 2013, Pages: 293–300, Xiayun Dai, Chen Wu, Yunfeng He, Lixuan Gui, Li Zhou, Huan Guo, Jing Yuan, Binyao Yang, Jun Li, Qifei Deng, Suli Huang, Lei Guan, Die Hu, Jiang Zhu, Xinwen Min, Mingjian Lang, Dongfeng Li, Handong Yang, Frank B. Hu, Dongxin Lin, Tangchun Wu and Meian He

    Version of Record online : 31 JAN 2013, DOI: 10.1002/gepi.21711

  17. OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 5, November 2012, Pages: 642–650, C S Lancaster, G H Bruun, C J Peer, T S Mikkelsen, T J Corydon, A A Gibson, S Hu, S J Orwick, R H J Mathijssen, W D Figg, S D Baker and A Sparreboom

    Version of Record online : 19 SEP 2012, DOI: 10.1038/clpt.2012.106

  18. Functional Characterization of Liver Enhancers That Regulate Drug-Associated Transporters

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 4, April 2011, Pages: 571–578, MJ Kim, P Skewes-Cox, H Fukushima, S Hesselson, SW Yee, LB Ramsey, L Nguyen, JL Eshragh, RA Castro, CC Wen, D Stryke, SJ Johns, TE Ferrin, P-Y Kwok, MV Relling, KM Giacomini, DL Kroetz and N Ahituv

    Version of Record online : 2 MAR 2011, DOI: 10.1038/clpt.2010.353

  19. Pharmacogenomics, Lipid Disorders, and Treatment Options

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 1, July 2014, Pages: 36–47, S E Gryn and R A Hegele

    Version of Record online : 10 APR 2014, DOI: 10.1038/clpt.2014.82

  20. You have free access to this content
    The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range

    British Journal of Clinical Pharmacology

    Volume 66, Issue 6, December 2008, Pages: 818–825, Annikka Kalliokoski, Mikko Neuvonen, Pertti J. Neuvonen and Mikko Niemi

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1365-2125.2008.03287.x